Proactive Investors
25 Jun 2026, 06:52 UTC · 1h ago
ImmuPharma appoints Bachem to manufacture key ingredient for diabetes drug
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Proactive Investors
25 Jun 2026, 06:52 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
ImmuPharma has appointed Bachem to produce the active pharmaceutical ingredient for its Kapiglucagon type 1 diabetes program. — Securing a global manufacturer is a key operational milestone that moves the drug candidate closer to clinical trials.
+0.40Tower Resources expects two farm-out deals in Namibia and Cameroon to potentially complete as early as July. — Completion of farm-out deals typically provides non-dilutive funding and validates asset quality.
+0.30Tower Resources has raised £400,000 to support working capital while awaiting government approvals in Namibia and Cameroon. — Small capital injection reduces immediate liquidity risk, though the amount is modest.
+0.20Which stocks this story touches
Continue reading
6 related stories
Top 1 mover · tap to explore
The company reached a milestone in its Kapiglucagon programme by appointing a manufacturer for its active pharmaceutical ingredient.
The company successfully raised £400,000 in working capital and expects potential deal completions in July.
The company is mentioned in a headline snippet without providing sufficient detail to assess sentiment.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Seeking Alpha
3h ago
